MedPath

Assessing current practice pattern and best practice sharing of usage of Coseal(Surgical Sealant)

Phase 4
Conditions
Health Condition 1: null- Surgery
Registration Number
CTRI/2012/10/003075
Lead Sponsor
Medanta The Medicity
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
750
Inclusion Criteria

1.Patients undergoing cardiovascular and thoracic surgery who require use of Coseal as a treatment strategy.

2.Patient undergoing open, Video Assisted surgery and robotic surgery to be included and analysed as subgroups

3.Written informed consent obtained from the patient or legal representative for data collection post surgery in patients who had Coseal used intraoperatively (data privacy laws).

Exclusion Criteria

1.Known hypersensitivity to components of the investigational product

2.Known Immune system disorders, immunodeficiency

3.Concomitant use of any other anti-adhesion product

4.Concurrently participating in another clinical trial and having received another investigational drug or device within the last 30 days

5.Unplanned re-operation in case of use for anti-adhesion

6.Contraindications for use of Coseal

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath